FB MEDICAL: what changed
FB MEDICAL
Largest movements
- Cash -€24,564
down €24,564 (-39.1%), from €62,778 to €38,214
mainly Contributions, distributions and other (-€30,000) and Net result for the year (-€14,936)
- Receivables within one year +€9,997
new in 2025: €9,997
- Profit (loss) carried forward -€44,936
down €44,936 (-73.6%), from €61,045 to €16,109
- Other debts +€30,000
up €30,000 (+11,040%), from €272 to €30,272
- Gross operating margin -€33,705
down €33,705, from €19,956 to -€13,750
- Taxes -€6,761
down €6,761, from €6,514 to -€247
- Other operating charges +€763
new in 2025: €763
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €63,428 | €48,380 | -€15,047 | -23.7% |
| Fixed assets | 21/28 | €650 | €170 | -€480 | -73.9% |
| Tangible fixed assets | 22/27 | €650 | €170 | -€480 | -73.9% |
| Plant, machinery and equipment | 23 | €265 | €82 | -€183 | -69.1% |
| Furniture and vehicles | 24 | €384 | €88 | -€297 | -77.1% |
| Current assets | 29/58 | €62,778 | €48,211 | -€14,567 | -23.2% |
| Amounts receivable within one year | 40/41 | - | €9,997 | +€9,997 | |
| Other amounts receivable | 41 | - | €9,997 | +€9,997 | |
| Cash at bank and in hand | 54/58 | €62,778 | €38,214 | -€24,564 | -39.1% |
| Total equity and liabilities | 10/49 | €63,428 | €48,380 | -€15,047 | -23.7% |
| Equity | 10/15 | €63,045 | €18,109 | -€44,936 | -71.3% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €61,045 | €16,109 | -€44,936 | -73.6% |
| Amounts payable | 17/49 | €383 | €30,272 | +€29,889 | +7,805% |
| Amounts payable within one year | 42/48 | €383 | €30,272 | +€29,889 | +7,805% |
| Trade debts | 44 | €111 | €0 | -€111 | -100% |
| Suppliers | 440/4 | €111 | €0 | -€111 | -100% |
| Other amounts payable | 47/48 | €272 | €30,272 | +€30,000 | +11,040% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €487 | €480 | -€7 | -1.5% |
| Other operating charges | 640/8 | - | €763 | +€763 | |
| Gross operating margin | 9900 | €19,956 | -€13,750 | -€33,705 | |
| Operating profit (loss) | 9901 | €19,469 | -€14,992 | -€34,461 | |
| Financial income | 75/76B | €0 | €0 | -€0 | -100% |
| Recurring financial income | 75 | €0 | €0 | -€0 | -100% |
| Financial charges | 65/66B | €205 | €190 | -€15 | -7.3% |
| Recurring financial charges | 65 | €205 | €190 | -€15 | -7.3% |
| Profit (loss) for the period before taxes | 9903 | €19,264 | -€15,183 | -€34,446 | |
| Income taxes | 67/77 | €6,514 | -€247 | -€6,761 | |
| Profit (loss) for the period | 9904 | €12,750 | -€14,936 | -€27,685 | |
| Profit (loss) for the period to be appropriated | 9905 | €12,750 | -€14,936 | -€27,685 |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.